Loading clinical trials...
Loading clinical trials...
Single-dose Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants
Conditions
Interventions
BMS-986141
Locations
3
United States
Clinical Pharmacology of Miami
Miami, Florida, United States
Clinical Research Center
Orlando, Florida, United States
Texas Liver Institute
San Antonio, Texas, United States
Start Date
January 11, 2017
Primary Completion Date
May 18, 2017
Completion Date
July 7, 2017
Last Updated
February 6, 2017
NCT07324616
NCT04271488
NCT06952634
NCT06841315
NCT06619054
NCT06813781
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions